Deferiprone therapy improves the oxidative status of LDL in patients with β-thalassaemia/HbE
Iron chelation therapy with L1 improves the oxidative status of LDL in patients with β-thalassaemia/HbE.
Authors
- Pranee Sutcharitchan
- Ponlapat Rojnuckarin (ORCID: https://orcid.org/0000-0001-7912-1996)
- Pakawit Lerksaipheng
- Rataya Luechapudiporn (ORCID: https://orcid.org/0000-0002-2327-5766)
- Noppawan Phumala Morales (ORCID: https://orcid.org/0000-0002-5365-2884)
- Ken‐ichi Yamada (ORCID: https://orcid.org/0000-0003-2100-8477)
- Tran Thi Ngan (ORCID: https://orcid.org/0000-0003-4514-713X)
Institutions
- Kyushu University (JP)
- Chulalongkorn University (TH)
- Mahidol University (TH)
Publication Details
- Journal
- Drugs in Context
- Published
- 2025-11-28
- DOI
- https://doi.org/10.7573/dic.2025-7-6
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00